title: Mitoxanthrone-induced acute myeloid leukaemia presenting with leukaemia cutis.
authors.affiliation: Dermatology Department.
authors.forename: John D
authors.initials: JD
authors.lastname: Fleming
authors.affiliation: Dermatology Department.
authors.forename: Sarah
authors.initials: S
authors.lastname: Walsh
authors.affiliation: Pathology Department.
authors.forename: Jon
authors.initials: J
authors.lastname: Salisbury
authors.affiliation: Dermatology Department.
authors.forename: Anthony W P
authors.initials: AW
authors.lastname: Du-Vivier
authors.affiliation: Haematology Department, King's College Hospital, London SE5 9RS, UK.
authors.forename: Ghulam
authors.initials: G
authors.lastname: Mufti
mesh_terms: D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000473:pathology*; D017254:Leukemic Infiltration / Q000209:etiology*; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy; D012867:Skin / Q000473:pathology*; D059005:Topoisomerase II Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D059005:Topoisomerase II Inhibitors; D008942:Mitoxantrone